Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05849064 · ClinicalTrials.gov registry record · NA

Concussion Treatment in Older Adults

A NA study of Concussion, Mild, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05849064 is a NA study of Concussion, Mild that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 50 participants, below the 201-participant average among 18 other Concussion, Mild trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05849064, a NA study of Concussion, Mild, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to conduct the first randomized control trial for targeted treatments for concussion in adults 50 years or older. Participants will be enrolled at their first concussion clinical visit (V1) and their second study visit will occur after (up to 7 days) or concurrently with the participant's second concussion clinical visit, typically (but not limited to) between 21-31 days from V1.

Conditions Studied

Interventions

  • BEHAVIORAL Behavioral Control
  • BEHAVIORAL Targeted Intervention

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-09-07
Est. Completion 2026-07
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT05849064

The ClinicalTrials.gov registry entry for NCT05849064 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 201-participant average among 18 other Concussion, Mild trials with a reported enrollment target (75% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Concussion, Mild appearing as the primary indexed condition, and to 2 interventions - of which Behavioral Control is the first listed.

NCT05849064 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05849064 about?

NCT05849064 is a clinical study titled "Concussion Treatment in Older Adults". The purpose of this study is to conduct the first randomized control trial for targeted treatments for concussion in adults 50 years or older. Participants will be enrolled at their first concussion clinical visit (V1) and their second study visit will occur after (up to 7 days) or concurrently with...

What is the current status of trial NCT05849064?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-09-07. Estimated completion is 2026-07.

What conditions does trial NCT05849064 study?

This clinical trial studies the following conditions: Concussion, Mild.

What interventions are being tested in trial NCT05849064?

The interventions under investigation include: Behavioral Control (BEHAVIORAL), Targeted Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05849064?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05849064 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Concussion, Mild

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.